Breast Lump
A page on symptoms in our womens health coverage, part of our health reporting, alongside the 7 reports filed on it so far.
Giredestrant-Everolimus Doubles Survival in ESR1-Mutated Breast Cancer
The evERA trial shows the all-oral combination of giredestrant and everolimus significantly improves progression-free survival for patients with...
FDA Grants Priority Review For Elinzanetant Hot Flash Treatment
The FDA has granted priority review to elinzanetant for treating hot flashes in women undergoing endocrine therapy for HR+ breast cancer.
Enhertu drug approved for NHS use in England
About 1,000 women a year in England with incurable HER2-low breast cancer will get the life-extending drug Enhertu on the NHS following a price deal.
FDA Approves Camizestrant for Early ESR1-Mutant Breast Cancer
The FDA granted accelerated approval to camizestrant for HR+/HER2- breast cancer when ESR1 resistance mutations are first detected during initial...
Insurance Denies Preventive Breast MRI Bill
A 43-year-old woman with a high breast cancer risk was billed $1,191.10 for a preventive MRI, despite pre-approval.
Biomarkers in Triple-Negative Breast Cancer: Progress and Unmet Needs
Despite advancements in biomarker testing for triple-negative breast cancer, more research is needed to improve treatment outcomes and address...
Infants Possibly Exposed to HIV via Breast Milk Donated Over Social Media
California health officials warn of the dangers of acquiring breast milk outside of vetted channels after multiple infants were potentially exposed...